MedTrace Logo

GLILD Diagnosed in Children and Young Adults With Common Variable Immunodeficiency

NCT03648567 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2018-08-27

No results posted yet for this study

Summary

8 to 22% of patients with common variable immunodeficiency (CVID) will develop Granulomatous Lymphocytic Interstitial Lung Disease (GLILD), which has emerged as a major cause of mortality. Little is known about GLILD in children and young adults. The aim of this study was to describe the clinical, functional, radiological and pathological features of children and young adults diagnosed with GLILD.

Conditions

  • GLILD in a Population of Children and Young Adults

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Fanny FOUYSSAC · CHRU Nancy

Eligibility

Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2018-09-01
Completion
2018-09-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648567 on ClinicalTrials.gov